Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Monday, September 28

8:10 AM - 8:20 AM ET

155 - Post-Chemoradiotherapy Molecular Residual Disease (MRD) Clearance Determines Long-Term Survival in Limited-Stage Small Cell Lung Cancer: A Prospective Longitudinal Study
Speaker: Tian, Yaru - Shandong Cancer Hospital and Institute, Jinan
8:10 AM - 8:20 AM ET

160 - Subregional Parotid Dosiomics and DVH Integration Improves Prediction of Xerostomia after Radiotherapy for Nasopharyngeal Carcinoma
Speaker: Sun, Hongfei, PhD - Xijing Hospital, Xian 710032, Shaanxi
8:15 AM - 8:20 AM ET

1026 - Intratumoral Immune Remodeling and Tumor Regression following Preoperative Radiation in Estrogen Receptor Positive Breast Cancer: Results from a Prospective Clinical Trial
Speaker: SenthilKumar, Gopika, BS - University of Wisconsin, Madison, WI
8:15 AM - 8:20 AM ET

1032 - Pilot Study of Tumor Treating Fields for Brainstem Gliomas
Speaker: Janopaul-Naylor, James, MD - Memorial Sloan Kettering Cancer Center, New York, NY
8:15 AM - 8:20 AM ET

1038 - Distinct Efficacy between Very Early-Onset Locally Advanced Rectal Cancer (VEO-LARC) and Late-Onset LARC Receiving Total Neoadjuvant Therapy with or without Immunotherapy
Speaker: Yan, Mingxu, MD - Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, Shanghai
8:20 AM - 8:25 AM ET

1027 - Association of Blood Count-Derived Inflammatory Indices with Capsular Contracture After Post-Mastectomy Radiotherapy in Breast Cancer Patients Undergoing Direct-to-Implant Reconstruction
Speaker: Lee, Jae Young, MD - Department of Radiation Oncology, Yonsei University College of Medicien, Yonsei Cancer Center, Seoul
8:20 AM - 8:25 AM ET

1033 - Neurocognitive Decline Occurs after Cranial Irradiation Independent of Tumor Infiltration and Chemotherapy: A Prospective Neurocognitive and Functional MRI Study
Speaker: Liu, Zhihua, PhD - Washington University School of Medicine in St Louis, St. Louis, MO
8:20 AM - 8:25 AM ET

1039 - CXCL12-Driven Anti-Tumor Neutrophil Infiltration Predicts Pathological Complete Response in pMMR Rectal Cancer Treated with Neoadjuvant SCRT and PD-1 Blockade
Speaker: He, Meng, MD, PhD - National Cancer Center/National Clinical Research Center for Cancer Cancer Hospital, CAMS & PUMC, Beijing, Beijing
8:20 AM - 8:30 AM ET

151 - Improving Access to Conformal Bolus Using Sheet Bolus and Piece-Wise Flat Geometry
Speaker: Stambaugh, Cassandra, PhD - Tufts Medical Center, Boston, MA
8:20 AM - 8:30 AM ET

156 - Prognostic Value of Baseline Genomic Profiling and Longitudinal ctDNA-Based MRD Monitoring in Limited-Stage Small-Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
Speaker: Huo, Siyuan - Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer and Tianjin Key Laboratory of Cancer Prevention and Therapy, Ti, Tianjin
8:20 AM - 8:30 AM ET

161 - Evaluating CT-based Radiomics and Dosiomics Outcome Models for Locoregionally Advanced Head and Neck Cancer: A Retrospective Analysis of the NRG/RTOG 0522 trial
Speaker: Tie, Xin, PhD - University of Pennsylvania, Philadelphia, PA
8:25 AM - 8:30 AM ET

1028 - Comparable Cosmetic Outcomes Across Racial and Age Groups After Dose-Escalated Five-Fraction Stereotactic Partial Breast Irradiation (S-PBI) on a Phase II Multicenter Trial
Speaker: Bolton, Chelsea - University of Texas Southwestern Medical Center at Dallas, Dallas, TX